종양 정보 시스템(OIS) 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2035년)

Oncology Information System (OIS) Market - Scope of Report

TMR's report on the global oncology information system (OIS) market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global oncology information system (OIS) market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global oncology information system (OIS) market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the oncology information system (OIS) market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global oncology information system (OIS) market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global oncology information system (OIS) market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global oncology information system (OIS) market.

The report delves into the competitive landscape of the global oncology information system (OIS) market. Key players operating in the global oncology information system (OIS) market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global oncology information system (OIS) market profiled in this report.

Key Questions Answered in global oncology information system (OIS) Market Report:

• What is the sales/revenue generated by oncology information system (OIS) across all regions during the forecast period?
• What are the opportunities in the global oncology information system (OIS) market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Oncology Information System (OIS) Market - Research Objectives and Research Approach

The comprehensive report on the global oncology information system (OIS) market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global oncology information system (OIS) market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global oncology information system (OIS) market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Oncology Information System (OIS) Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Oncology Information System (OIS) Market Analysis and Forecast, 2020-2035
  • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

• 5.1. Technology Analysis
• 5.2. Pricing Analysis
• 5.3. PESTEL Analysis
• 5.4. Regulatory Scenario by Region/Country
• 5.5. PORTER's Five Forces Analysis
• 5.6. Key Industry Events
• 5.7. Unmet Needs of the Market
• 5.8. Key Purchase Metrics for End-users

6. Global Oncology Information System (OIS) Market Analysis and Forecast, by Solution

• 6.1. Introduction & Definition
• 6.2. Key Findings/Developments
• 6.3. Market Value Forecast, by Solution, 2020-2035
  • 6.3.1. Software
    • 6.3.1.1. Patient Information Systems
      • 6.3.1.1.1. Electronic Medical Records
      • 6.3.1.1.2. Laboratory Information Systems
      • 6.3.1.1.3. Radiology Information Systems
      • 6.3.1.1.4. Others
    • 6.3.1.2. Treatment Planning Systems
      • 6.3.1.2.1. Clinical Decision Support Systems
      • 6.3.1.2.2. Brachytherapy Treatment Planning Systems
      • 6.3.1.2.3. Others
  • 6.3.2. Services
• 6.4. Market Attractiveness Analysis, by Solution

7. Global Oncology Information System (OIS) Market Analysis and Forecast, by Application

• 7.1. Introduction & Definition
• 7.2. Key Findings/Developments
• 7.3. Market Value Forecast, by Application, 2020-2035
  • 7.3.1. Medical Oncology
  • 7.3.2. Radiation Oncology
  • 7.3.3. Surgical Oncology
• 7.4. Market Attractiveness Analysis, by Application

8. Global Oncology Information System (OIS) Market Analysis and Forecast, by End-user

• 8.1. Introduction & Definition
• 8.2. Key Findings/Developments
• 8.3. Market Value Forecast, by End-user, 2020-2035
  • 8.3.1. Hospitals & Ambulatory Surgical Centers
  • 8.3.2. Diagnostic & Imaging Centers
  • 8.3.3. Ablation & Cancer Care Centers
  • 8.3.4. Others
• 8.4. Market Attractiveness Analysis, by End-user

9. Global Oncology Information System (OIS) Market Analysis and Forecast, by Region

• 9.1. Key Findings
• 9.2. Market Value Forecast, by Region, 2020-2035
  • 9.2.1. North America
  • 9.2.2. Europe
  • 9.2.3. Asia Pacific
  • 9.2.4. Latin America
  • 9.2.5. Middle East & Africa
• 9.3. Market Attractiveness Analysis, by Region

10. North America Oncology Information System (OIS) Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast, by Solution, 2020-2035
  • 10.2.1. Software
    • 10.2.1.1. Patient Information Systems
      • 10.2.1.1.1. Electronic Medical Records
      • 10.2.1.1.2. Laboratory Information Systems
      • 10.2.1.1.3. Radiology Information Systems
      • 10.2.1.1.4. Others
    • 10.2.1.2. Treatment Planning Systems
      • 10.2.1.2.1. Clinical Decision Support Systems
      • 10.2.1.2.2. Brachytherapy Treatment Planning Systems
      • 10.2.1.2.3. Others
  • 10.2.2. Services
• 10.3. Market Value Forecast, by Application, 2020-2035
  • 10.3.1. Medical Oncology
  • 10.3.2. Radiation Oncology
  • 10.3.3. Surgical Oncology
• 10.4. Market Value Forecast, by End-user, 2020-2035
  • 10.4.1. Hospitals & Ambulatory Surgical Centers
  • 10.4.2. Diagnostic & Imaging Centers
  • 10.4.3. Ablation & Cancer Care Centers
  • 10.4.4. Others
• 10.5. Market Value Forecast, by Country, 2020-2035
  • 10.5.1. U.S.
  • 10.5.2. Canada
• 10.6. Market Attractiveness Analysis
  • 10.6.1. By Solution
  • 10.6.2. By Application
  • 10.6.3. By End-user
  • 10.6.4. By Country

11. Europe Oncology Information System (OIS) Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast, by Solution, 2020-2035
  • 11.2.1. Software
    • 11.2.1.1. Patient Information Systems
      • 11.2.1.1.1. Electronic Medical Records
      • 11.2.1.1.2. Laboratory Information Systems
      • 11.2.1.1.3. Radiology Information Systems
      • 11.2.1.1.4. Others
    • 11.2.1.2. Treatment Planning Systems
      • 11.2.1.2.1. Clinical Decision Support Systems
      • 11.2.1.2.2. Brachytherapy Treatment Planning Systems
      • 11.2.1.2.3. Others
  • 11.2.2. Services
• 11.3. Market Value Forecast, by Application, 2020-2035
  • 11.3.1. Medical Oncology
  • 11.3.2. Radiation Oncology
  • 11.3.3. Surgical Oncology
• 11.4. Market Value Forecast, by End-user, 2020-2035
  • 11.4.1. Hospitals & Ambulatory Surgical Centers
  • 11.4.2. Diagnostic & Imaging Centers
  • 11.4.3. Ablation & Cancer Care Centers
  • 11.4.4. Others
• 11.5. Market Value Forecast, by Country/Sub-region, 2020-2035
  • 11.5.1. Germany
  • 11.5.2. UK
  • 11.5.3. France
  • 11.5.4. Italy
  • 11.5.5. Spain
  • 11.5.6. Rest of Europe
• 11.6. Market Attractiveness Analysis
  • 11.6.1. By Solution
  • 11.6.2. By Application
  • 11.6.3. By End-user
  • 11.6.4. By Country/Sub-region

12. Asia Pacific Oncology Information System (OIS) Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Solution, 2020-2035
  • 12.2.1. Software
    • 12.2.1.1. Patient Information Systems
      • 12.2.1.1.1. Electronic Medical Records
      • 12.2.1.1.2. Laboratory Information Systems
      • 12.2.1.1.3. Radiology Information Systems
      • 12.2.1.1.4. Others
    • 12.2.1.2. Treatment Planning Systems
      • 12.2.1.2.1. Clinical Decision Support Systems
      • 12.2.1.2.2. Brachytherapy Treatment Planning Systems
      • 12.2.1.2.3. Others
  • 12.2.2. Services
• 12.3. Market Value Forecast, by Application, 2020-2035
  • 12.3.1. Medical Oncology
  • 12.3.2. Radiation Oncology
  • 12.3.3. Surgical Oncology
• 12.4. Market Value Forecast, by End-user, 2020-2035
  • 12.4.1. Hospitals & Ambulatory Surgical Centers
  • 12.4.2. Diagnostic & Imaging Centers
  • 12.4.3. Ablation & Cancer Care Centers
  • 12.4.4. Others
• 12.5. Market Value Forecast, by Country/Sub-region, 2020-2035
  • 12.5.1. China
  • 12.5.2. Japan
  • 12.5.3. India
  • 12.5.4. Australia & New Zealand
  • 12.5.5. Rest of Asia Pacific
• 12.6. Market Attractiveness Analysis
  • 12.6.1. By Solution
  • 12.6.2. By Application
  • 12.6.3. By End-user
  • 12.6.4. By Country/Sub-region

13. Latin America Oncology Information System (OIS) Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Solution, 2020-2035
  • 13.2.1. Software
    • 13.2.1.1. Patient Information Systems
      • 13.2.1.1.1. Electronic Medical Records
      • 13.2.1.1.2. Laboratory Information Systems
      • 13.2.1.1.3. Radiology Information Systems
      • 13.2.1.1.4. Others
    • 13.2.1.2. Treatment Planning Systems
      • 13.2.1.2.1. Clinical Decision Support Systems
      • 13.2.1.2.2. Brachytherapy Treatment Planning Systems
      • 13.2.1.2.3. Others
  • 13.2.2. Services
• 13.3. Market Value Forecast, by Application, 2020-2035
  • 13.3.1. Medical Oncology
  • 13.3.2. Radiation Oncology
  • 13.3.3. Surgical Oncology
• 13.4. Market Value Forecast, by End-user, 2020-2035
  • 13.4.1. Hospitals & Ambulatory Surgical Centers
  • 13.4.2. Diagnostic & Imaging Centers
  • 13.4.3. Ablation & Cancer Care Centers
  • 13.4.4. Others
• 13.5. Market Value Forecast, by Country/Sub-region, 2020-2035
  • 13.5.1. Brazil
  • 13.5.2. Mexico
  • 13.5.3. Rest of Latin America
• 13.6. Market Attractiveness Analysis
  • 13.6.1. By Solution
  • 13.6.2. By Application
  • 13.6.3. By End-user
  • 13.6.4. By Country/Sub-region

14. Middle East & Africa Oncology Information System (OIS) Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast, by Solution, 2020-2035
  • 14.2.1. Software
    • 14.2.1.1. Patient Information Systems
      • 14.2.1.1.1. Electronic Medical Records
      • 14.2.1.1.2. Laboratory Information Systems
      • 14.2.1.1.3. Radiology Information Systems
      • 14.2.1.1.4. Others
    • 14.2.1.2. Treatment Planning Systems
      • 14.2.1.2.1. Clinical Decision Support Systems
      • 14.2.1.2.2. Brachytherapy Treatment Planning Systems
      • 14.2.1.2.3. Others
  • 14.2.2. Services
• 14.3. Market Value Forecast, by Application, 2020-2035
  • 14.3.1. Medical Oncology
  • 14.3.2. Radiation Oncology
  • 14.3.3. Surgical Oncology
• 14.4. Market Value Forecast, by End-user, 2020-2035
  • 14.4.1. Hospitals & Ambulatory Surgical Centers
  • 14.4.2. Diagnostic & Imaging Centers
  • 14.4.3. Ablation & Cancer Care Centers
  • 14.4.4. Others
• 14.5. Market Value Forecast, by Country/Sub-region, 2020-2035
  • 14.5.1. GCC Countries
  • 14.5.2. South Africa
  • 14.5.3. Rest of Middle East & Africa
• 14.6. Market Attractiveness Analysis
  • 14.6.1. By Solution
  • 14.6.2. By Application
  • 14.6.3. By End-user
  • 14.6.4. By Country/Sub-region

15. Competition Landscape

• 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 15.2. Market Share Analysis, by Company (2024)
• 15.3. Company Profiles
  • 15.3.1. Varian Medical Systems
    • 15.3.1.1. Company Overview
    • 15.3.1.2. Financial Overview
    • 15.3.1.3. Product Portfolio
    • 15.3.1.4. Business Strategies
    • 15.3.1.5. Recent Developments
  • 15.3.2. Elekta
    • 15.3.2.1. Company Overview
    • 15.3.2.2. Financial Overview
    • 15.3.2.3. Product Portfolio
    • 15.3.2.4. Business Strategies
    • 15.3.2.5. Recent Developments
  • 15.3.3. Philips Healthcare
    • 15.3.3.1. Company Overview
    • 15.3.3.2. Financial Overview
    • 15.3.3.3. Product Portfolio
    • 15.3.3.4. Business Strategies
    • 15.3.3.5. Recent Developments
  • 15.3.4. Cerner
    • 15.3.4.1. Company Overview
    • 15.3.4.2. Financial Overview
    • 15.3.4.3. Product Portfolio
    • 15.3.4.4. Business Strategies
    • 15.3.4.5. Recent Developments
  • 15.3.5. Epic Systems Corporation
    • 15.3.5.1. Company Overview
    • 15.3.5.2. Financial Overview
    • 15.3.5.3. Product Portfolio
    • 15.3.5.4. Business Strategies
    • 15.3.5.5. Recent Developments
  • 15.3.6. McKesson
    • 15.3.6.1. Company Overview
    • 15.3.6.2. Financial Overview
    • 15.3.6.3. Product Portfolio
    • 15.3.6.4. Business Strategies
    • 15.3.6.5. Recent Developments
  • 15.3.7. Flatiron Health
    • 15.3.7.1. Company Overview
    • 15.3.7.2. Financial Overview
    • 15.3.7.3. Product Portfolio
    • 15.3.7.4. Business Strategies
    • 15.3.7.5. Recent Developments
  • 15.3.8. Siemens Healthineers
    • 15.3.8.1. Company Overview
    • 15.3.8.2. Financial Overview
    • 15.3.8.3. Product Portfolio
    • 15.3.8.4. Business Strategies
    • 15.3.8.5. Recent Developments
  • 15.3.9. ViewRay, Inc.
    • 15.3.9.1. Company Overview
    • 15.3.9.2. Financial Overview
    • 15.3.9.3. Product Portfolio
    • 15.3.9.4. Business Strategies
    • 15.3.9.5. Recent Developments
  • 15.3.10. Accuray Incorporated
    • 15.3.10.1. Company Overview
    • 15.3.10.2. Financial Overview
    • 15.3.10.3. Product Portfolio
    • 15.3.10.4. Business Strategies
    • 15.3.10.5. Recent Developments
  • 15.3.11. BrainLab
    • 15.3.11.1. Company Overview
    • 15.3.11.2. Financial Overview
    • 15.3.11.3. Product Portfolio
    • 15.3.11.4. Business Strategies
    • 15.3.11.5. Recent Developments
  • 15.3.12. Oracle (Cerner Corporation)
    • 15.3.12.1. Company Overview
    • 15.3.12.2. Financial Overview
    • 15.3.12.3. Product Portfolio
    • 15.3.12.4. Business Strategies
    • 15.3.12.5. Recent Developments
  • 15.3.13. RaySearch Laboratories
    • 15.3.13.1. Company Overview
    • 15.3.13.2. Financial Overview
    • 15.3.13.3. Product Portfolio
    • 15.3.13.4. Business Strategies
    • 15.3.13.5. Recent Developments